Unexpected neuroprotection observed with the adenosine A2A receptor agonist CGS 21680

Drug Development Research

Volumn 39, Issue 1, 1996, Pages 108-114

  Sheardown, Malcolm I ^a   Knutsen, Lars J S ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Cerebral ischemia; DPMA; Metrifudil; Purinoreceptors

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; METRIFUDIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; REPERFUSION INJURY;

EID: 0030511902     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2299(19960901)39:1<108::aid-ddr8>3.0.co;2-j     Document Type: Article

References (33)

1. Abbracchio MP, Brambilla R, Camisa M, Rovati GE, Ferrari R, Canevari L, Dagani F, Catabeni F (1995): Adenosine AI receptors in rat brain synaptosoines: Transductional mechanisms, effects on glutamate release, and preservation after metabolic inhibition. Drug Dev Res 35:119-129.
2. 2 receptor. J Med Chem 31:1282-1285.
3. Bullock R, Zauner A, Woodward J, Young HF (1995): Massive persistent increase of excitatory amino acids following human occlusive stroke. Stroke 26:2187-2189.
4. Cronstein BN (1994): Adenosine, an endogenous antiinflammatory agent. J Appl Physiol 76:5-13.
5. 1 receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: A quantitative autoradiographic study. Brain Res 491:212-226.
6. Dolphin AC, Prestwich SA (1985): Pertussis toxin reverses adenosine inhibition of neural glutamate release. Nature 316:148-150.
7. Dux E, Fastbom J, Ungerstedt U, Rudolphi K, Fredholm BB (1990): Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res 516:248-256.
8. Evans MC, Swan JH, Meldrum BS (1987): An adenosine analogue, 2-chloroadenosine protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci Lett 83:287-292.
9. 3H]-glutamate release from rat hippocampal slices by L-PIA. Acta Physiol Scand 125:121-123.
10. Fredholm BB (1995): Adenosine receptors in the central nervous system. News Physiol Sci 10:122-128.
11. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Williams M (1994): Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
12. 2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci 55:PL61-65.
13. 2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251:47-35.
14. Jacobson KA, van Galen PJM, Williams M (1992): Adenosine receptors: Pharmacology, structure-activity relationships and therapeutic potential. J Med Chem 35:407-422.
15. 2 agonist, CCS 21680. Pharmacol Biochem Behav 45:913-919.
16. 3H] CGS 21680. Eur J Pharmacol 168:243-246.
17. 3H] CGS 21G80 to rat brain using autoradiography. Neuropharmacology 34:393-403.
18. 2 receptor ligands in different chemoconvulsive models. Eur J Pharmacol 224:221-228.
19. Knutsen LJS, Lau J, Eskesen K, Sheardown MJ, Thomsen C, Weis JU, Judge ME, Klitgaard H (1995): Anticonvulsant actions of novel and reference adenosine agonists. In Belardinelli L, Pelleg A (eds): Adenosine and Adenosine Nucleotides: From Molecular Biology to Integrative Physiology. Norwell, MA: Kluwer Academic Publishers, pp 479-487.
20. Marangos PJ (1991): Potential therapeutic roles for adenosine in neurologic disease. In Stone TW (ed): Adenosine in the Nervous System. London: Academic Press Ltd., pp 217-226.
21. Miller LP, Hsu C (1992): Therapeutic potential for adenosine receptor activation in ischemic brain injury. J Neurotrauma 9:S563-S577.
22. 1-selective adenosine agonists. J Med Chem 28:1383-1384.
23. Palmer TM, Stiles CL (1994): The new biology of adenosine receptors. Adv Enzymol Relat Areas Mol Biol 69:83-120.
24. Phillis JW (1989): Adenosine in control of cerebral circulation. Cerebrovasc Brain Metab Rev 1:26-54.
25. Rudolphi KA, Keil M, Grome JJ (1990): Adenosine: A pharmacological concept for the treatment of cerebral ischemia? In Kriegelstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, pp 439-448.
26. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB (1992): Neuroprotective role of adenosine in cerebral ischemia. TIPS 439-445.
27. Sheardown MJ, Hansen AJ, Thomsen C, Judge ME, Knutsen LJS (1995) Novel adenosine agonists: A strategy for stroke therapy. In Grotta J, Miller L, Buchan AM (eds): Ischemic Stroke: Recent Advances in Understanding and Therapy. International Business Communications, pp 187-214.
28. Simpson RE, O'Regan MH, Perkins LM, Phillis JW (1992): Excitatory transmitter release from the ischemic rat cerebral cortex: Effects of adenosine receptor agonists and antagonists. J Neurochem 58:1683-1690.
29. von Lubitz DKJE, Dambrosia JM, Kempski O, Redmond D (1988): Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of the gerbil hippocampus. Stroke 19:1133-1139.
30. von Lubitz DKJE, Carter ME Beenhakker M, Lin RCS, Jacobson KA (1995a): Adenosine: A prototherapeutic concept in neurodegeneration. Ann NY Acad Sci 765:163-178.
31. 2A receptor agonist and antagonist. Eur J Pharmacol 287:295-302.
32. Williams M (1984): Adenosine: A selective neuromodulator in the mammalian CNS? TINS 164-168.
33. 1 receptors underlies anticonvulsant effect of CGS21680. Eur J Pharmacol 255:239-243.